Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

ELMD stock hub

Electromed, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ELMDis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
222.9M
NYSEAMERICAN
Market data

Live price

Current market quote for this ticker.

Current price
ELMD
In the news

Latest news · ELMD

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22.5
P25 12.3P50 18.4P75 33.1
Trailing P/E26.1
P25 14.9P50 23.2P75 38.5
ROE20.2
P25 -105.6P50 -46.5P75 -3.1
ROIC28
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ELMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
258
Groups with data
11
Currency
USD
Showing 258 of 258 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001488917
Company name
Electromed, Inc.
Country
United States
Country code
US
Cusip
285409108
Employees
180
Employees Change
6%
Employees Change Percent
3.45
Enterprise value
$209.2M
Exchange
NYSEAMERICAN
Financial currency
USD
First seen
2026-05-09
Industry
Medical Devices
IPO Date
2010-08-13
Isin
US2854091087
Last refreshed
2026-05-10
Market cap
$222.9M
Market cap category
Micro-Cap
Price
$26.93
Price currency
USD
Rev Per Employee
382,561.11x
Sector
Healthcare
Sic
3845
Symbol
ELMD
Website
https://smartvest.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

17
MetricValue
Earnings Yield
4.03%
EV Earnings
23.26x
EV Sales Forward
2.67x
EV/EBIT
17.9x
EV/EBITDA
16.24x
EV/FCF
25.35x
EV/Sales
3.04x
FCF yield
3.7%
Forward P/E
22.5x
P/B ratio
4.91x
P/E ratio
26.15x
P/S ratio
3.24x
PE Ratio10 Y
28.45x
PE Ratio3 Y
28.6x
PE Ratio5 Y
34.01x
PEG ratio
1.03x
PS Forward
2.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
16.96%
EBITDA Margin
18.7%
FCF margin
11.98%
Gross margin
78.23%
Gross Profit
$53.9M
Gross Profit Growth
17.62%
Gross Profit Growth Q
17.36%
Gross Profit Growth3 Y
17.9%
Gross Profit Growth5 Y
15.81%
Net Income
$9M
Net Income Growth
32.96%
Net Income Growth Q
40.3%
Net Income Growth Quarters
13%
Net Income Growth Years
3%
Net Income Growth3 Y
62.75%
Net Income Growth5 Y
19.44%
Pretax Margin
17.41%
Profit Margin
13.06%
Profit Per Employee
$49,956
Profitable Years
11
ROA
13.62
Roa5y
7.22
ROCE
25.65
ROE
20.2
Roe5y
10.6
ROIC
28.04
Roic5y
14.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

24
MetricValue
Cagr10y
19.05%
Cagr15y
15.14%
Cagr1y
22.48%
Cagr3y
33.76%
Cagr5y
22.76%
EPS Growth
37.55
EPS Growth Q
45.46
EPS Growth Quarters
13
EPS Growth Years
3
EPS Growth3 Y
64.85
EPS Growth5 Y
20.2
FCF Growth
-24.47%
FCF Growth Q
-18.03%
FCF Growth5 Y
19.15%
OCF Growth
-19.22%
OCF Growth Q
-3.97%
OCF Growth10 Y
13.28%
OCF Growth5 Y
20.03%
Revenue Growth
15.49x
Revenue Growth Q
16.25x
Revenue Growth Quarters
21x
Revenue Growth Years
12x
Revenue Growth3 Y
16.28x
Revenue Growth5 Y
15.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
$1.28
Assets
$54.9M
Cash
$13.8M
Current Assets
$45.6M
Current Liabilities
$9.4M
Debt
$96,000
Debt EBITDA
$0.01
Debt Equity
$0
Debt FCF
$0.01
Equity
$45.4M
Liabilities
$9.5M
Long Term Assets
$9.3M
Long Term Liabilities
$96,000
Net Cash
$13.7M
Net Cash By Market Cap
$6.15
Net Cash Growth
-15.08%
Net Debt EBITDA
$-1.06
Net Debt Equity
$-0.3
Net Debt FCF
$-1.66
Tangible Book Value
$44M
Tangible Book Value Per Share
$5.31
WACC
6.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
4.86
Inventory Turnover
4.59
Net Working Capital
$22.4M
Quick ratio
4.39
Working Capital
$36.2M
Working Capital Turnover
$1.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
2.18%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
471.76%
1Y total return
22.47%
200-day SMA
24.98
3Y total return
139.38%
50-day SMA
24.67
50-day SMA vs 200-day SMA
50under200
5Y total return
178.78%
All Time High
35.56
All Time High Change
-24.27%
All Time High Date
2025-01-30
All Time Low
0.9
All Time Low Change
2,887.24%
All Time Low Date
2013-09-13
ATR
0.88
Beta
0.39
Beta1y
0.75
Beta2y
0.69
Ch YTD
-7.52
High
27.24
High52
30.73
High52 Date
2026-02-02
High52ch
-12.37%
Low
26.75
Low52
17.73
Low52 Date
2025-08-01
Low52ch
51.89%
Ma50ch
9.15%
Price vs 200-day SMA
7.82%
RSI
63.6
RSI Monthly
56.99
RSI Weekly
55.71
Sharpe ratio
0.58x
Sortino ratio
0.95
Total Return
2.18%
Tr YTD
-7.52
Tr15y
728.62%
Tr1m
13.25%
Tr1w
5.2%
Tr3m
-7.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

18
MetricValue
Analyst Count
3
Analyst Count Top
1
Analyst Price Target Top
$36
Analyst Ratings
Strong Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$0.25
Earnings EPS Estimate Growth
19.05
Earnings Revenue Estimate
17,594,000x
Earnings Revenue Estimate Growth
12.18x
Operating Income
$11.7M
Operating Income Growth
34.96
Operating Income Growth Q
42.41
Operating Income Growth3 Y
63.43
Operating Income Growth5 Y
27.01
Operating margin
16.96
Price target
$36
Price Target Change
$33.68
Price Target Change Top
$33.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
6,489,635%
Float Percent
78.42%
Shares Insiders
21.58%
Shares Institutions
59.63%
Shares Out
8,275,313
Shares Qo Q
0.09%
Shares Yo Y
-2.18%
Short Float
2.49%
Short Ratio
3.45
Short Shares
1.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

68
MetricValue
Adjusted FCF
$5.7M
Average Volume
32,090.55x
Bv Per Share
5.49
CAPEX
$-878,000
Ch10y
471.8
Ch15y
728.6
Ch1m
13.25
Ch1w
5.2
Ch1y
22.47
Ch3m
-7.49
Ch3y
139.4
Ch5y
178.8
Ch6m
11.42
Change
0.26%
Change From Open
0.64
Close
26.86
Days Gap
-0.37
Depreciation Amortization
1,197,000
Dollar Volume
778,169.3
Earnings Date
2026-05-12
Earnings Time
amc
EBIT
$11.7M
EBITDA
$12.9M
EPS
$1.03
F Score
6
FCF
$8.3M
FCF EV Yield
3.94x
FCF Per Share
$1
Financing CF
-10,638,000
Fiscal Year End
June
Founded
1,992
Graham Number
11.27706
Graham Upside
-58.12
Income Tax
$3M
Investing CF
-934,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-02-10
Last Report Date
2025-12-31
Last Split Type
Never
Last10k Filing Date
2025-08-26
Lynch Fair Value
$20.02
Lynch Upside
-25.66
Ma150
26
Ma150ch
3.56%
Ma20
25.74
Ma20ch
4.61%
Net CF
-2,444,000
Next Earnings Date
2026-05-12
Open
26.76
Optionable
Yes
P FCF Ratio
27.01
P OCF Ratio
24.41
Position In Range
36.73
Ppne
5,379,000
Price Date
2026-05-08
Price EBITDA
$17.3
Ptbv Ratio
5.07
Relative Volume
0.9x
Revenue
68,861,000x
SBC By Revenue
3.66x
Share Based Comp
2,521,000
Tax By Revenue
4.35x
Tax Rate
25%
Tr6m
11.42%
Us State
Minnesota
Volume
28,896
Z Score
16.41
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ELMD pay a dividend?

Capital-return profile for this ticker.

Performance

ELMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+22.5%
S&P 500 1Y: n/a
3Y total return
+139.4%
S&P 500 3Y: n/a
5Y total return
+178.8%
S&P 500 5Y: n/a
10Y total return
+471.8%
S&P 500 10Y: n/a
Ownership

Who owns ELMD?

Insider, institutional, and short-interest positioning.

Institutional ownership
+59.6%
Float: +78.4% of shares outstanding
Insider ownership
+21.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+2.5%
3.5 days to cover
Y/Y dilution
-2.2%
Negative means the company is buying back shares.
Technical

ELMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
63.6
Neutral momentum band
Price vs 200-day MA
+7.8%
50/200-day relationship not available
Beta (5Y)
0.39
Less volatile than the market
Sharpe ratio
0.58
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ELMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ELMD stock rating?

Electromed, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ELMD analysis?

The full report lives at /stocks/ELMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ELMD?

The latest report frames ELMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ELMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.